Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome

Hamster-Adapted Sin Nombre Virus Causes Disseminated Infection and Efficiently Replicates in Pulmonary Endothelial Cells without Signs of Disease

(2013) D. Safronetz et al.   JOURNAL OF VIROLOGY

The Syrian hamster model of hantavirus pulmonary syndrome

(2012) David Safronetz et al.   ANTIVIRAL RESEARCH

Favipiravir (T-705) inhibits in vitro norovirus replication

(2012) J. Rocha-Pereira et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vaccines for hantaviruses: progress and issues

(2012) Connie S Schmaljohn   Expert Review of Vaccines

DNA Vaccine-Generated Duck Polyclonal Antibodies as a Postexposure Prophylactic to Prevent Hantavirus Pulmonary Syndrome (HPS)

(2012) Rebecca Brocato et al.   PLoS One

In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection

(2011) David Safronetz et al.   PLoS One

Hantavirus pulmonary syndrome

(2011) Adam MacNeil et al.   VIRUS RESEARCH

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

(2011) Michelle Mendenhall et al.   PLoS Neglected Tropical Diseases

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus

(2011) David Safronetz et al.   PLoS Pathogens

T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture

(2010) Michelle Mendenhall et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses

(2010) K. Sleeman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease

(2010) C. B. Jonsson et al.   CLINICAL MICROBIOLOGY REVIEWS

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

(2009) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Adenovirus Vectors Expressing Hantavirus Proteins Protect Hamsters against Lethal Challenge with Andes Virus

(2009) D. Safronetz et al.   JOURNAL OF VIROLOGY

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

(2009) M. Kiso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents

(2008) J MORREY et al.   ANTIVIRAL RESEARCH

Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea

(2008) Janice M. Rusnak et al.   ANTIVIRAL RESEARCH

Treatment of hantavirus pulmonary syndrome

(2007) Colleen B. Jonsson et al.   ANTIVIRAL RESEARCH

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL